Solution For Global GMP Oversight Elusive, FDA Commissioner Says
This article was originally published in The Pink Sheet Daily
Executive Summary
Margaret Hamburg says FDA will have to share inspections with sister regulatory agencies abroad - but acknowledges that the problems will not be completely solved during her tenure.
You may also be interested in...
Foreign Manufacturing Cost-Savings Might Be Offset By Regulatory Due Diligence, FDA's Woodcock Cautions
Companies may have more work down the line dealing with regulatory authorities if they manufacture products in foreign countries not following an accepted regulatory structure.
Foreign Manufacturing Cost-Savings Might Be Offset By Regulatory Due Diligence, FDA's Woodcock Cautions
Companies may have more work down the line dealing with regulatory authorities if they manufacture products in foreign countries not following an accepted regulatory structure.
Hamburg Offers Warning Letter "Close-Out" In Plan To Speed Enforcement
FDA Commissioner Margaret Hamburg is including a carrot for industry - a warning letter close-out process - in a multi-stick initiative to strengthen the agency's enforcement program